Editorial: Challenges associated with identifying preclinical animal models for the development of immune-based therapies

• Kainat Jamil,
• Shardulendra P. Sherchand,
• Rajan P. Adhikari,
• An Coosemans

Affiliations

Kainat Jamil

Department of Oncology, Laboratory of Tumor Immunology and Immunotherapy, Katholieke Universiteit (KU) Leuven, Leuven, Belgium

Shardulendra P. Sherchand

Bacteriological Immunotherapy, AbVacc Inc., Rockville, MD, United States

Rajan P. Adhikari

Bacteriological Immunotherapy, AbVacc Inc., Rockville, MD, United States

An Coosemans

Department of Oncology, Laboratory of Tumor Immunology and Immunotherapy, Katholieke Universiteit (KU) Leuven, Leuven, Belgium